The National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is recruiting for a Tenure-Track or Tenure-Eligible Investigator to direct an innovative research program within its Intramural Research Program (IRP). The goal of this search is to identify a candidate who will enhance this collaborative environment through the development of a novel and cutting- edge clinical research program related to understanding fundamental brain mechanisms of drug addiction using functional and/or structural based imaging, behavioral and computational methods and other innovative human laboratory approaches.
We are seeking a candidate who is committed to scientific excellence and understands the intellectual benefits of collaborative research to enhance and increase emerging areas of human based research. Applicants must hold an MD and/or PhD or equivalent degree(s). Criteria for selection include experience in conducting human subject-based neuroimaging research relevant to fundamental mechanisms and constructs relevant to drug addiction, including (but not limited to) the neural basis of learning, decision-making, affective and cognitive control. Approaches utilizing frameworks that offer high potential for cross-species translation and collaboration (e.g., computational modeling), are particularly valued, as a major goal of this hire is to catalyze the bidirectional movement of ideas between preclinical basic science and human/clinical research groups at the IRP. On the latter note, the ideal candidate for this position is someone who can lead his/her own program while also establishing and being part of collaborative efforts with the other PIs in the clinical program as well as with the basic scientists at NIDA. The position can be filled as either a Tenure-Track or Tenure-Eligible Investigator and the ideal candidate will have a productive publication track record and experience in the conceptualization, development, execution, completion and publication of human studies and clinical protocols in the addiction field.
The selected candidate will receive independent resources from NIDA for funding start-up costs and on-going program operations and will be responsible for managing these resources (budget, human resources and space). NIDA will provide clinical, laboratory and office space adequate to establish an outstanding human research program at the Biomedical Research Center, located on the Johns Hopkins Bayview Campus in Baltimore, MD. The broader NIH campus and the NIDA IRP in Baltimore provide a rich and highly interactive tional neuroscience environment. Full federal benefits are included. Salary will be commensurate with experience.
Appointees may be U.S. citizens, resident aliens, or non-resident aliens with, or eligible to obtain, a valid employment authorization visa. Interested candidates must submit a Curriculum Vitae (including bibliography), a two-page summary of research interests, and the names and contact information (work/email addresses, phone) of three references (via pdf or MS Word format only – paper applications will not be accepted) to: Adrienne Snyder, Management Analyst, NIDA IRP at firstname.lastname@example.org. Please also provide a description of mentoring and outreach activities (not to exceed 1 page) in which you have been involved, especially those involving women and persons from racial/ethnic and other groups that are underrepresented in biomedical research.
Review of applications will begin on March 30, 2020, and continue until the position is filled
The NIH encourages the application and nomination of qualified women, minorities and individuals with disabilities.
The HHS and NIH are Equal Opportunity Employers
Internal Number: WM20-002181
About National Institutes of Health, National Institute on Drug Abuse, Intramural Research Program
The mission of the Intramural Research Program (IRP) of the National Institute on Drug Abuse is to conduct state-of-the-art research on basic mechanisms that underlie drug abuse and addiction, and to develop new methods for the treatment of drug abuse and addiction. Research is supported at the molecular, genetic, cellular, animal, and clinical levels and is conceptually integrated, highly innovative, and focused on major problems in the field. The long-term goal of the research is to better understand the biological and behavioral factors contributing to initiation, maintenance, and elimination of drug abuse and addiction (and associated diseases), and to translate this knowledge into improved strategies for preventing, treating, and reducing the negative consequences for the individual and for society caused by drug abuse and addiction. An important aspect of the program is the training of young investigators and career development of more experienced investigators in basic and clinical sciences related to drug abuse research.